Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,442 across all filing types
Latest filing 2022-02-03 Capital/Financing Update
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
BPAY or EFT Process for IMUOC & IMUOD Option Holders 4 pages 937.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement from Imugene Limited dated 4 February 2022. It provides detailed instructions and forms for exercising listed options (IMUOC and IMUOD) via BPAY or EFT. The content focuses on the process for option holders to exercise their options, including payment details and contact information for the share registry. There is no financial data, earnings information, management discussion, or regulatory certification. It is not a report or announcement of voting results, board changes, or legal matters. The document is essentially a procedural notice to shareholders about exercising options, which falls under capital or financing activities related to share options. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive content about financing activity, not just a brief notice or report publication announcement.
2022-02-03 English
Application for quotation of securities - IMU 12 pages 41.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, prices, and whether the securities rank equally with existing shares. The document is a regulatory announcement related to capital changes but does not constitute a full financial report or earnings release. It is not a report publication announcement since it contains substantive details about the securities issued and converted. This fits the definition of a Share Issue/Capital Change announcement.
2022-02-03 English
Application for quotation of securities - IMU 10 pages 34.5KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by Imugene Limited. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital market activities, specifically the listing of new securities. This fits the category of Capital/Financing Update (CAP) as it concerns updates on securities issuance and quotation on the exchange.
2022-02-03 English
Notice Under Section 708A 1 page 167.1KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 4 February 2022, providing a notice under Section 708A(5) of the Corporations Act 2001. It details the issuance of ordinary shares under an employee incentive scheme, including the number of shares issued and issue prices. The notice confirms compliance with relevant provisions of the Corporations Act and states that the shares were issued without disclosure under Part 6D.2 of the Act. This type of document is a regulatory announcement about share issuance and compliance, specifically a notice related to share capital changes but not a full financial report or earnings release. Given the content and the nature of the announcement, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and focused on a specific capital change event, not a report or presentation.
2022-02-03 English
Appointment of Dr Steven Cha as Chief Medical Officer 3 pages 79.4KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement regarding the appointment of Dr. Steven Cha as Chief Medical Officer of Imugene Limited. It focuses on management changes and provides detailed background information about the new appointee. There is no financial data, no mention of financial results, no regulatory filings or report attachments, and no shareholder voting information. The content clearly fits the category of announcing changes in senior management rather than any other report or announcement type.
2022-01-31 English
Notification regarding unquoted securities - IMU 10 pages 36.6KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed notification regarding the issue of unquoted equity securities, specifically unlisted options issued under an employee incentive scheme. It includes specifics such as the number of securities issued, exercise prices, expiry dates, and references to ASX listing rules and previous AGM notices for terms of the securities. The document is not a full financial report, earnings release, or management discussion, but rather a formal announcement of securities issuance. This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues or capital changes. The document length and detail confirm it is the announcement itself, not just a brief notice or a report publication announcement.
2022-01-31 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.